Top 25 Companies in Global Arthritis Therapeutics Market: Statistics Report Till 2035

Description

According to a research report published by Spherical Insights & Consulting, the global arthritis therapeutics market size is projected to grow from USD 83.4 Billion in 2025 to USD 146.2 Billion by 2035, at a CAGR of 5.7% during the forecast period 2026–2035. The worldwide arthritis therapeutics market experiences growth because of rising arthritis cases and the expanding elderly population and the development of new treatment methods and the increasing public understanding of early detection and successful disease management.

 

Introduction

The global arthritis therapeutics market refers to the segment of the healthcare industry that focuses on the development and distribution of drugs and treatment solutions for various types of arthritis, including osteoarthritis, rheumatoid arthritis, and psoriatic arthritis. The therapeutics deliver efficient results through their application in hospital and clinical and homecare environments which effectively reduce pain and manage inflammation and enhance joint movement. Untreated disease progression results in worse health outcomes which arthritis therapeutics successfully treat through their clinically proven effectiveness. The market is expanding steadily due to the rising prevalence of arthritis, increasing geriatric population, growing awareness about early diagnosis, and favorable healthcare policies and reimbursement scenarios. The development of biologics and targeted therapies and personalized medicine improvements lead to better treatment results and safer healthcare options. The healthcare sector gains advantages from better access to medical services which drives up demand for ongoing disease treatment. The physical therapy and lifestyle changes of patients with arthritis get enhanced through arthritis therapeutics which help doctors treat their patients fully. The global healthcare sector shows continuous expansion in chronic disease treatment markets which demonstrates the rising need for advanced treatments around the world.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Arthritis Therapeutics Market.

 

Market Segmentation

Global Arthritis Therapeutics Market Size, Share, By Product Type (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-Rheumatoid Drugs (DMARDs), Biologics, and Others), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 – 2035

 

Arthritis Therapeutics Market Size & Statistics

• The Market Size for Arthritis Therapeutics Was Estimated to be worth USD 83.4 Billion in 2025.
• The Market is Going to Expand at a CAGR of 5.7% between 2026 and 2035.
• The Global Arthritis Therapeutics Market Size is anticipated to reach USD 146.2 Billion by 2035.
• North America is expected to generate the highest revenue during the forecast period in the Arthritis Therapeutics Market
• Asia Pacific is expected to grow at the fastest rate during the forecast period in the Arthritis Therapeutics Market.

 

Regional growth and demand                                     

Asia Pacific is expected to grow at the fastest rate during the forecast period in the arthritis therapeutics market. The Asia-Pacific region will experience the fastest market growth during the forecast period according to the global arthritis therapeutics market because of its increasing elderly population and rising arthritis cases and better healthcare facilities and growing health awareness and spending in emerging markets such as China and India.

 

North America is expected to generate the highest revenue during the forecast period in the arthritis therapeutics market. North America will produce the most revenue during the forecast period for the global arthritis therapeutics market because of its high arthritis rates and its advanced healthcare system and its significant pharmaceutical company presence and its growing use of new treatment methods.

 

 

Top 10 Trends in the Arthritis Therapeutics Market

• Rising adoption of biologics and biosimilars
• Growth of targeted therapies (JAK inhibitors, IL inhibitors)
• Increasing prevalence of arthritis globally
• Shift toward personalized medicine
• Strong pipeline of innovative drugs
• Patent expiry of blockbuster drugs
• Rising healthcare expenditure in emerging markets
• Advancements in drug delivery systems
• Integration of AI in drug discovery
• Growing focus on early diagnosis and disease management

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Arthritis Therapeutics Market.

 

1. Rising adoption of biologics and biosimilars

The development of biologics which target specific immune system elements has created new treatment options for arthritis that show better results than conventional medications. The therapies see common application in treating both rheumatoid arthritis and psoriatic arthritis. The development of biosimilars emerged as a response to high product costs, which provide customers with less expensive options that maintain comparable treatment results and safety standards. The increasing approval and adoption of biosimilars are improving patient access to advanced treatments, especially in emerging markets. The current trend helps decrease healthcare expenses while preserving treatment standards, which creates a major boost to market expansion.

 

2. Growth of targeted therapies (JAK inhibitors, IL inhibitors)

People use targeted therapies which include Janus kinase (JAK) inhibitors and interleukin (IL) inhibitors because these treatments provide precise solutions for arthritis management. The therapies operate through specific pathways which control both inflammation and immune system functions, in contrast to traditional medications which treat general health issues. The patient experience results in superior results because of this method, which maintains better disease control with fewer unwanted reactions. People find oral JAK inhibitors more practical than they find injectable biologics. The constant development of new treatments together with their regulatory approvals, now provides expanded treatment options which serve as a major factor driving growth within the arthritis therapeutics industry.

 

3. Increasing prevalence of arthritis globally

The rising prevalence of arthritis throughout the world occurs because people age while they adopt inactive habits and develop obesity and sustain joint injuries. The two most common forms of arthritis which affect people worldwide include osteoarthritis and rheumatoid arthritis. The number of people with chronic joint conditions continues to increase as life expectancy extends. The growing number of patients who require treatment creates a strong need for effective solutions which combine disease management with methods that relieve their suffering. The arthritis therapeutics market expands because governments and healthcare organizations develop programs for public education and early disease identification.

 

4. Shift toward personalized medicine

Arthritis treatment now follows personalized medicine which customizes therapies according to individual patient characteristics that include their genetic makeup and illness severity and treatment response. This approach improves treatment effectiveness and reduces the risk of adverse effects. Healthcare providers now utilize advanced biomarker research and diagnostic tools to identify the most effective treatment options for each patient. Personalized medicine also supports better disease monitoring and long-term management. The arthritis therapeutics market experiences growth because it improves patient satisfaction while creating new treatment options.

 

5. Strong pipeline of innovative drugs

The arthritis therapeutics market is supported by a robust pipeline of innovative drugs under development. Pharmaceutical companies are heavily investing in research and development to introduce new therapies that will offer better efficacy and safety and convenience. The current clinical trials are testing new drug classes and combination treatments and next-generation biologic therapies. The innovations through these developments will solve existing medical problems while delivering better long-term results for patients. The market will experience increased competition through the introduction of new medications which will create additional treatment alternatives that will drive substantial growth in the arthritis therapeutics market.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the arthritis therapeutics market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Arthritis Therapeutics Market.

 

Top 25 Companies Leading the Arthritis Therapeutics Market

1. AbbVie Inc.
2. Pfizer Inc.
3. Amgen Inc.
4. Johnson & Johnson
5. Bristol-Myers Squibb
6. Hoffmann-La Roche Ltd
7. Novartis AG
8. Sanofi S.A.
9. Eli Lilly and Company
10. UCB S.A.
11. Gilead Sciences, Inc.
12. Merck & Co., Inc.
13. Bayer AG
14. GlaxoSmithKline plc
15. Regeneron Pharmaceuticals
16. Boehringer Ingelheim
17. Celltrion Inc.
18. Samsung Bioepis
19. Sandoz Group AG
20. Viatris Inc.
21. Aclaris Therapeutics
22. Horizon Therapeutics
23. Kiniksa Pharmaceuticals
24. Taisho Pharmaceutical
25. R-Pharm

 

1. AbbVie Inc.

Headquarters: North Chicago, Illinois, USA, North America

AbbVie Inc. stands as a prominent biopharmaceutical enterprise which controls a major portion of the arthritis treatment sector. The company is well known for its blockbuster drug Humira, which doctors prescribe for rheumatoid arthritis and other autoimmune diseases. AbbVie develops advanced biologics and immunology treatments through its comprehensive research and development capabilities. The company upholds its dominant market position through its international operations and dedication to developing next-generation medical solutions. AbbVie establishes its authority in the arthritis treatment industry through its strategic partnerships and its expansion of research projects.

 

2. Pfizer Inc.

Headquarters: New York, USA, North America

Pfizer Inc. operates as a worldwide pharmaceutical corporation which maintains a substantial role in the arthritis treatment market. The company provides groundbreaking medical solutions through its targeted therapies which include Xeljanz, a JAK inhibitor that treats rheumatoid arthritis. Pfizer invests heavily in research and development to enhance treatment effectiveness and patient outcomes. The company distributes its products through a robust global distribution network which it supports with essential strategic partnerships. The company continues to expand its immunology portfolio, reinforcing its position as a key player in arthritis therapeutics.

 

3. Amgen Inc.

Headquarters: Thousand Oaks, California, USA, North America

Amgen Inc. has established itself as the leading biotechnology company which develops cutting-edge biologic treatments for chronic illnesses that include arthritis. The company’s key products, such as Enbrel, are widely used in the treatment of rheumatoid arthritis and other inflammatory conditions. Amgen focuses on advanced biologics and biosimilars to improve treatment accessibility and affordability. The organization uses its extensive research capabilities and international operations to create future medical treatments. The company maintains a strong market position in arthritis therapeutics through its strategic partnerships and ongoing research and development efforts.

 

4. Johnson & Johnson

Headquarters: New Brunswick, New Jersey, USA, North America

Johnson & Johnson operates as a diversified healthcare organization which establishes a powerful presence in the arthritis therapeutics market through its Janssen pharmaceutical division. The company provides effective biologic solutions which include Remicade and Stelara for the treatment of autoimmune arthritis diseases. Johnson & Johnson uses its worldwide research capabilities to create new therapies which treat chronic diseases. The company sustains its position as the top player in the worldwide arthritis therapeutics industry through its extensive distribution system and its continuous financial support for immunology research.

 

5. Bristol-Myers Squibb

Headquarters: New York, USA, North America

Bristol-Myers Squibb has established itself as a top biopharmaceutical company which develops advanced immunology and arthritis treatment solutions. The drug Orencia developed by the company functions as a primary treatment option for rheumatoid arthritis, providing patients effective disease management. Bristol-Myers Squibb uses research-based product development to create solutions which focus on patient needs in order to boost treatment results. The company advances arthritis therapeutics through its worldwide operations and new treatment development work while sustaining its competitive edge in the marketplace.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Arthritis Therapeutics Market.

 

Are you ready to discover more about the arthritis therapeutics market?

The report provides an in-depth analysis of the leading companies operating in the global arthritis therapeutics market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. AbbVie Inc.

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

2. Pfizer Inc.
3. Amgen Inc.
4. Johnson & Johnson
5. Bristol-Myers Squibb
6. Hoffmann-La Roche Ltd
7. Novartis AG
8. Sanofi S.A.
9. Eli Lilly and Company
10. Others.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Arthritis Therapeutics Market.

 

Conclusion

The global arthritis therapeutics market is experiencing continuous expansion because of three factors which include rising arthritis cases and an increasing elderly population and advancements in drug development and supportive healthcare policies. The effectiveness of arthritis therapeutics enables patients to manage their pain while controlling their inflammation and restoring their joint function, which results in better quality of life. The development of biologics and targeted therapies and personalized medicine results in better treatment outcomes and increased treatment dependability. The major companies AbbVie Inc. Pfizer Inc. Amgen Inc. Johnson & Johnson and Bristol-Myers Squibb are expanding their operations worldwide to enhance market growth. The use of arthritis therapeutics provides essential benefits which help healthcare systems worldwide to improve their disease management capabilities.

 

Our Reports:

North America Protective Relay Market Size, Forecast to 2035
North America Air Pollution Control Systems Market Size, Forecast to 2035
Pyridine Market Size, Statistics, Forecast to 2035
North America Organic Coffee Market Size, Forecast to 2035

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter